🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NRI
$NRIX
🔒 US EquitiesNurix Therapeutics Inc
AVG HISTORICAL GAP
+1.13%
MAX GAP RECORD
-10.59%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NRIX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NRIX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 13, 2026 Earnings Release 2026-10-13 (BEFORE OPEN (02:00)) |
+0.00%
|
| Jul 09, 2026 Earnings Release 2026-07-09 (AFTER CLOSE) |
+0.69%
|
| Apr 08, 2026 Earnings Release 2026-04-08 (BEFORE OPEN) |
+1.35%
|
| Jan 28, 2026 Earnings Release 2026-01-28 (AFTER CLOSE) |
+2.13%
|
| Oct 09, 2025 Earnings Release 2025-10-09 (AFTER CLOSE) |
-10.59%
|
| Jul 09, 2025 Earnings Release 2025-07-09 (AFTER CLOSE) |
+9.86%
|
| Apr 08, 2025 Earnings Release 2025-04-08 (AFTER CLOSE) |
-0.97%
|
| Jan 28, 2025 Earnings Release 2025-01-28 (AFTER CLOSE) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.1%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (4)
📖 Intelligence Summary
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗